Rifampin reduces plasma concentrations and effects of zolpidem

[1]  P. Neuvonen,et al.  Concentrations and effects of zopiclone are greatly reduced by rifampicin. , 1997, British journal of clinical pharmacology.

[2]  P. Neuvonen,et al.  Triazolam is ineffective in patients taking rifampin , 1997, Clinical pharmacology and therapeutics.

[3]  E. Perucca,et al.  Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine , 1996, Clinical pharmacokinetics.

[4]  P. Neuvonen,et al.  Concentrations and Effects of Oral Midazolam are Greatly Reduced in Patients Treated with Carbamazepine or Phenytoin , 1996, Epilepsia.

[5]  G. Bessard,et al.  Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection. , 1996, Journal of chromatography. B, Biomedical applications.

[6]  P. Neuvonen,et al.  Rifampin drastically reduces plasma concentrations and effects of oral midazolam , 1996, Clinical pharmacology and therapeutics.

[7]  C. Bonfils,et al.  Oxidative metabolism of zolpidem by human liver cytochrome P450S. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[8]  J. Kolars,et al.  Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. , 1992, The Journal of clinical investigation.

[9]  K. Klimek,et al.  Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam. , 1990, International journal of clinical pharmacology, therapy, and toxicology.

[10]  P. Benfield,et al.  Zolpidem , 1990, Drugs.

[11]  J. Derancourt,et al.  Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[12]  N. Brockmeyer,et al.  The effect of antipyrine and rifampin on the metabolism of diazepam , 1987, Clinical pharmacology and therapeutics.

[13]  A. Richens,et al.  Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance. , 1984, British journal of clinical pharmacology.

[14]  K. Venkatesan.  Pharmacokinetic Drug Interactions with Rifampicin , 1992, Clinical pharmacokinetics.